Diabetic retinopathy is a retinal microvascular disease that often causes blindness in adults who have had diabetes mellitus for 10 years or more. Estimates are that 600 million people will have some sort of diabetic retinopathy by 2040.
FDA Approves Test for Spontaneous Preterm Birth
QIAGEN won FDA’s OK to introduce its PartoSure test for estimating the risk of spontaneous preterm birth to be used for women that are experiencing symptoms of preterm labor. The test identifies the presence of placental alpha microglobulin-1 (PAMG-1), a pretty good indicator that the fetal membrane has suffered a break. The test has alr (Read more...)
Printing Functional Electronics Directly Onto Skin
University of Minnesota researchers have figured out a way of printing electronics on top of skin, even onto hands that are unrestrained and slightly moving. We got a peek at the technology in the Fall of last year, when it was first presented at the 2017 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS) in […]
Uncategorized
Global Vision Care Market 2018-2022: Rise in Product Launches Driving Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Vision Care Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering. The global vision care market to grow at a CAGR of 4.25% during the period 2018-2022. Global Vision Care Market 2018-2022, ha…
Uncategorized
Stem cell-based retinal implant shows promising results for advanced dry AMD
A first-of-its-kind stem cell-based retinal implant for patients with advanced dry age-related macular degeneration was well-tolerated and showed promising early efficacy in a phase 1/2a study.
Researchers evaluated the use of human embryonic stem cells implanted in patients with advanced dry AMD. The study evaluated the primary safety of the treatment and noted any restoration of vision or prevention of vision loss in a patient cohort, lead author Amir H. Kashani, MD, PhD, assistant professor of clinical ophthalmology at the Keck School of Medicine of USC, told Healio.com/OSN.
“The idea
Shockwave’s S4 Catheter Shakes Calcified Plaque Off Peripheral Arteries
Shockwave Medical, out of Freemont California, won European regulatory approval to introduce its Shockwave S4 Peripheral Intravascular Lithotripsy Catheter. The catheter can be used to work on arteries below the knees, shocking them with ultrasound to displace plaque compacted to the vessel walls. The frequency of the ultrasound is tuned to the res (Read more...)